

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.36667339 |
| 2 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.00465845 |
| 3 | chaperone-mediated protein transport (GO:0072321) | 3.96259036 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.95666685 |
| 5 | viral transcription (GO:0019083) | 3.89431340 |
| 6 | maturation of SSU-rRNA (GO:0030490) | 3.83749871 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 3.81410339 |
| 8 | DNA deamination (GO:0045006) | 3.78988211 |
| 9 | translational termination (GO:0006415) | 3.75064031 |
| 10 | proteasome assembly (GO:0043248) | 3.74199972 |
| 11 | positive regulation of T cell apoptotic process (GO:0070234) | 3.67458679 |
| 12 | oxidative phosphorylation (GO:0006119) | 3.64524934 |
| 13 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.61780918 |
| 14 | formation of translation preinitiation complex (GO:0001731) | 3.59795199 |
| 15 | protein maturation by protein folding (GO:0022417) | 3.57661983 |
| 16 | base-excision repair, AP site formation (GO:0006285) | 3.56993114 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.56852744 |
| 18 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.55969103 |
| 19 | cotranslational protein targeting to membrane (GO:0006613) | 3.47666937 |
| 20 | translational elongation (GO:0006414) | 3.45774833 |
| 21 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.45346897 |
| 22 | protein targeting to ER (GO:0045047) | 3.45183958 |
| 23 | macromolecular complex disassembly (GO:0032984) | 3.42125545 |
| 24 | negative regulation of B cell apoptotic process (GO:0002903) | 3.41243725 |
| 25 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.41147964 |
| 26 | ATP synthesis coupled proton transport (GO:0015986) | 3.40436098 |
| 27 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.40436098 |
| 28 | establishment of protein localization to mitochondrion (GO:0072655) | 3.36050515 |
| 29 | protein localization to endoplasmic reticulum (GO:0070972) | 3.33402771 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.31392866 |
| 31 | GTP biosynthetic process (GO:0006183) | 3.30304812 |
| 32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.30259247 |
| 33 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.25336501 |
| 34 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.23766024 |
| 35 | termination of RNA polymerase III transcription (GO:0006386) | 3.23033904 |
| 36 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.23033904 |
| 37 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.22015643 |
| 38 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.21652279 |
| 39 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.21370687 |
| 40 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.19632615 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.19124071 |
| 42 | ribosomal large subunit biogenesis (GO:0042273) | 3.18557288 |
| 43 | purine nucleobase biosynthetic process (GO:0009113) | 3.18531646 |
| 44 | protein neddylation (GO:0045116) | 3.18224869 |
| 45 | UTP biosynthetic process (GO:0006228) | 3.18134567 |
| 46 | translation (GO:0006412) | 3.15889906 |
| 47 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.15486967 |
| 48 | GDP-mannose metabolic process (GO:0019673) | 3.14761155 |
| 49 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.14669528 |
| 50 | regulation of mitochondrial translation (GO:0070129) | 3.13570802 |
| 51 | protein targeting to membrane (GO:0006612) | 3.13308142 |
| 52 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.13225159 |
| 53 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.10618341 |
| 54 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.09438764 |
| 55 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.09438764 |
| 56 | translational initiation (GO:0006413) | 3.09178739 |
| 57 | deoxyribonucleotide catabolic process (GO:0009264) | 3.08668249 |
| 58 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.08177891 |
| 59 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.08177891 |
| 60 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.08177891 |
| 61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.07992316 |
| 62 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.07896587 |
| 63 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.07776009 |
| 64 | respiratory chain complex IV assembly (GO:0008535) | 3.05763964 |
| 65 | cytochrome complex assembly (GO:0017004) | 3.05213627 |
| 66 | pentose metabolic process (GO:0019321) | 3.04085218 |
| 67 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.03832691 |
| 68 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.01546616 |
| 69 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.01546616 |
| 70 | respiratory electron transport chain (GO:0022904) | 3.00990605 |
| 71 | nucleobase biosynthetic process (GO:0046112) | 3.00612380 |
| 72 | protein localization to mitochondrion (GO:0070585) | 3.00388201 |
| 73 | L-methionine salvage (GO:0071267) | 2.99794719 |
| 74 | L-methionine biosynthetic process (GO:0071265) | 2.99794719 |
| 75 | amino acid salvage (GO:0043102) | 2.99794719 |
| 76 | viral life cycle (GO:0019058) | 2.98804073 |
| 77 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.98657486 |
| 78 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.96351057 |
| 79 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.96351057 |
| 80 | protein complex biogenesis (GO:0070271) | 2.96136769 |
| 81 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.95498495 |
| 82 | negative regulation of ligase activity (GO:0051352) | 2.95498495 |
| 83 | rRNA metabolic process (GO:0016072) | 2.95076979 |
| 84 | electron transport chain (GO:0022900) | 2.94749986 |
| 85 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94609525 |
| 86 | ncRNA 3-end processing (GO:0043628) | 2.94451572 |
| 87 | GMP metabolic process (GO:0046037) | 2.94144384 |
| 88 | deoxyribose phosphate catabolic process (GO:0046386) | 2.92872902 |
| 89 | DNA strand elongation (GO:0022616) | 2.92463437 |
| 90 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.92422265 |
| 91 | iron-sulfur cluster assembly (GO:0016226) | 2.92102563 |
| 92 | metallo-sulfur cluster assembly (GO:0031163) | 2.92102563 |
| 93 | telomere maintenance via recombination (GO:0000722) | 2.92041088 |
| 94 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.89672056 |
| 95 | cellular protein complex disassembly (GO:0043624) | 2.89023080 |
| 96 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.88482552 |
| 97 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.85136232 |
| 98 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.85136232 |
| 99 | NADH dehydrogenase complex assembly (GO:0010257) | 2.85136232 |
| 100 | mRNA catabolic process (GO:0006402) | 2.83546686 |
| 101 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.82874116 |
| 102 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.82741029 |
| 103 | rRNA modification (GO:0000154) | 2.81925549 |
| 104 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.81806811 |
| 105 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81397784 |
| 106 | CTP biosynthetic process (GO:0006241) | 2.81321089 |
| 107 | CTP metabolic process (GO:0046036) | 2.81321089 |
| 108 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.80100166 |
| 109 | aerobic respiration (GO:0009060) | 2.76722032 |
| 110 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.76112032 |
| 111 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.75518699 |
| 112 | UTP metabolic process (GO:0046051) | 2.75417912 |
| 113 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.75252785 |
| 114 | cellular component biogenesis (GO:0044085) | 2.73498738 |
| 115 | tooth mineralization (GO:0034505) | 2.73233433 |
| 116 | T cell apoptotic process (GO:0070231) | 2.71985893 |
| 117 | tRNA modification (GO:0006400) | 2.71840335 |
| 118 | RNA catabolic process (GO:0006401) | 2.71697015 |
| 119 | cytidine catabolic process (GO:0006216) | 2.70529171 |
| 120 | peptidyl-histidine modification (GO:0018202) | 2.69197383 |
| 121 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.69144444 |
| 122 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.68506706 |
| 123 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.65917988 |
| 124 | NADH metabolic process (GO:0006734) | 2.64660878 |
| 125 | 7-methylguanosine mRNA capping (GO:0006370) | 2.59844219 |
| 126 | ubiquinone biosynthetic process (GO:0006744) | 2.59677915 |
| 127 | quinone biosynthetic process (GO:1901663) | 2.59677915 |
| 128 | positive regulation of ligase activity (GO:0051351) | 2.59444826 |
| 129 | response to interferon-beta (GO:0035456) | 2.56853650 |
| 130 | pseudouridine synthesis (GO:0001522) | 2.52472563 |
| 131 | IMP biosynthetic process (GO:0006188) | 2.52205454 |
| 132 | RNA capping (GO:0036260) | 2.51270110 |
| 133 | 7-methylguanosine RNA capping (GO:0009452) | 2.51270110 |
| 134 | tricarboxylic acid cycle (GO:0006099) | 2.47517496 |
| 135 | positive regulation of cell cycle arrest (GO:0071158) | 2.46348505 |
| 136 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.46345884 |
| 137 | rRNA processing (GO:0006364) | 2.45405115 |
| 138 | DNA replication initiation (GO:0006270) | 2.45066689 |
| 139 | DNA replication checkpoint (GO:0000076) | 2.44425081 |
| 140 | mitotic recombination (GO:0006312) | 2.41271890 |
| 141 | protein complex disassembly (GO:0043241) | 2.41162654 |
| 142 | IMP metabolic process (GO:0046040) | 2.39800624 |
| 143 | protein targeting to mitochondrion (GO:0006626) | 2.39161638 |
| 144 | telomere maintenance via telomere lengthening (GO:0010833) | 2.38624893 |
| 145 | ribosome biogenesis (GO:0042254) | 2.38510174 |
| 146 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.38113848 |
| 147 | transcription from RNA polymerase I promoter (GO:0006360) | 2.37182512 |
| 148 | termination of RNA polymerase I transcription (GO:0006363) | 2.36787798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.36629636 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.63220114 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.51286186 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.28520506 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.25712564 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.22892011 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.17584316 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03881952 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.85803778 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.84470708 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.66832705 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59395064 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.47580137 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.41249338 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.31766437 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.29475992 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.24311962 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.24266110 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.23589531 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.16978283 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.11293276 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.04935240 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.02710274 |
| 24 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.00730325 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.00044391 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99189424 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.96892404 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96219770 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.92964510 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.89463446 |
| 31 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.89424617 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88831717 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87761112 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.87562422 |
| 35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.87100144 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.83705274 |
| 37 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82841308 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.81013778 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.80738811 |
| 40 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79558812 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79349590 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.78104407 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74477623 |
| 44 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72645969 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.72402660 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71365624 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.70597577 |
| 48 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.70204672 |
| 49 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67505512 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63137867 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.62580890 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.58113085 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.55850097 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.55757251 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.55564109 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53745860 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52798881 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.51200795 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.50350818 |
| 60 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.46794854 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43359179 |
| 62 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.42694773 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41848592 |
| 64 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.41518917 |
| 65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.40643558 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38775096 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38376589 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.36729632 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35510627 |
| 70 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.34699566 |
| 71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.34312770 |
| 72 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32766351 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32346422 |
| 74 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.31502350 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.30856931 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30340787 |
| 77 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.29321435 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 1.28383106 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27830062 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27683259 |
| 81 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25318767 |
| 82 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24926068 |
| 83 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24614312 |
| 84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.22887752 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22600036 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21820148 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21656405 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.21372530 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20615659 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20615511 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16514221 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13588251 |
| 93 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13172268 |
| 94 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.12402843 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11453614 |
| 96 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09872952 |
| 97 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08198976 |
| 98 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07636148 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06130056 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05971111 |
| 101 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05781159 |
| 102 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05198353 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04625513 |
| 104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03668183 |
| 105 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03424264 |
| 106 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03343363 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03038919 |
| 108 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02987170 |
| 109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02476975 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02311720 |
| 111 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01966354 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01159966 |
| 113 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01110396 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00305065 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98811453 |
| 116 | P300_27268052_Chip-Seq_Bcells_Human | 0.98398140 |
| 117 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.97971532 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96497577 |
| 119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96398190 |
| 120 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96169330 |
| 121 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95760644 |
| 122 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95339927 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95256679 |
| 124 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94791048 |
| 125 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93871576 |
| 126 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93292863 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.92968422 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92412292 |
| 129 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91440722 |
| 130 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.91409124 |
| 131 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89360906 |
| 132 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89160105 |
| 133 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87895727 |
| 134 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.87791396 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87538240 |
| 136 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86277068 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86164419 |
| 138 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.83468157 |
| 139 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.82700285 |
| 140 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82585010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.16412124 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.08012047 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.91605237 |
| 4 | MP0003693_abnormal_embryo_hatching | 2.77082273 |
| 5 | MP0009785_altered_susceptibility_to | 2.59618946 |
| 6 | MP0000678_abnormal_parathyroid_gland | 2.59454976 |
| 7 | MP0003186_abnormal_redox_activity | 2.53438167 |
| 8 | MP0005670_abnormal_white_adipose | 2.30215060 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 2.28636408 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.11800782 |
| 11 | MP0005360_urolithiasis | 2.11700002 |
| 12 | MP0001853_heart_inflammation | 2.11642856 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.09160533 |
| 14 | MP0005671_abnormal_response_to | 2.06302314 |
| 15 | MP0000049_abnormal_middle_ear | 2.05696886 |
| 16 | MP0003646_muscle_fatigue | 2.03237245 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.03215690 |
| 18 | MP0004957_abnormal_blastocyst_morpholog | 2.01734953 |
| 19 | MP0002653_abnormal_ependyma_morphology | 2.01408306 |
| 20 | MP0005379_endocrine/exocrine_gland_phen | 1.95526761 |
| 21 | MP0008057_abnormal_DNA_replication | 1.88974020 |
| 22 | MP0000685_abnormal_immune_system | 1.86114889 |
| 23 | MP0005025_abnormal_response_to | 1.85639293 |
| 24 | MP0002132_abnormal_respiratory_system | 1.85443507 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.84709741 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.81127989 |
| 27 | MP0003724_increased_susceptibility_to | 1.76806996 |
| 28 | MP0005085_abnormal_gallbladder_physiolo | 1.75412125 |
| 29 | MP0003077_abnormal_cell_cycle | 1.74076751 |
| 30 | MP0009840_abnormal_foam_cell | 1.72462529 |
| 31 | MP0005365_abnormal_bile_salt | 1.71582274 |
| 32 | MP0001764_abnormal_homeostasis | 1.69824163 |
| 33 | MP0010094_abnormal_chromosome_stability | 1.69762418 |
| 34 | MP0004147_increased_porphyrin_level | 1.69309936 |
| 35 | MP0003111_abnormal_nucleus_morphology | 1.69114614 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.66184052 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.63420470 |
| 38 | MP0008058_abnormal_DNA_repair | 1.62174687 |
| 39 | MP0003436_decreased_susceptibility_to | 1.60266606 |
| 40 | MP0001800_abnormal_humoral_immune | 1.59602061 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59452149 |
| 42 | MP0005410_abnormal_fertilization | 1.58021780 |
| 43 | MP0006082_CNS_inflammation | 1.55356753 |
| 44 | MP0002723_abnormal_immune_serum | 1.54878675 |
| 45 | MP0002163_abnormal_gland_morphology | 1.53087279 |
| 46 | MP0005387_immune_system_phenotype | 1.48984164 |
| 47 | MP0001790_abnormal_immune_system | 1.48984164 |
| 48 | MP0002419_abnormal_innate_immunity | 1.48737699 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.47227908 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.46728614 |
| 51 | MP0001819_abnormal_immune_cell | 1.45957808 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.45300264 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.44869219 |
| 54 | MP0008469_abnormal_protein_level | 1.44040339 |
| 55 | MP0009379_abnormal_foot_pigmentation | 1.42053428 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.40729742 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.40685737 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.40002494 |
| 59 | MP0002398_abnormal_bone_marrow | 1.38787969 |
| 60 | MP0000681_abnormal_thyroid_gland | 1.37632891 |
| 61 | MP0009053_abnormal_anal_canal | 1.35217331 |
| 62 | MP0005332_abnormal_amino_acid | 1.35139925 |
| 63 | MP0003786_premature_aging | 1.34698910 |
| 64 | MP0002249_abnormal_larynx_morphology | 1.33570642 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.32497370 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.32497370 |
| 67 | MP0001727_abnormal_embryo_implantation | 1.30744675 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.30386704 |
| 69 | MP0005451_abnormal_body_composition | 1.29967644 |
| 70 | MP0001905_abnormal_dopamine_level | 1.29173627 |
| 71 | MP0000716_abnormal_immune_system | 1.26633039 |
| 72 | MP0002722_abnormal_immune_system | 1.25289218 |
| 73 | MP0003195_calcinosis | 1.25126271 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.24769347 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.23280001 |
| 76 | MP0002429_abnormal_blood_cell | 1.22267860 |
| 77 | MP0002405_respiratory_system_inflammati | 1.19941588 |
| 78 | MP0000858_altered_metastatic_potential | 1.18671774 |
| 79 | MP0005646_abnormal_pituitary_gland | 1.17645926 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 1.17412340 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.16619874 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 1.15870302 |
| 83 | MP0005389_reproductive_system_phenotype | 1.15610954 |
| 84 | MP0005058_abnormal_lysosome_morphology | 1.14541268 |
| 85 | MP0002160_abnormal_reproductive_system | 1.14508880 |
| 86 | MP0005083_abnormal_biliary_tract | 1.13850025 |
| 87 | MP0005464_abnormal_platelet_physiology | 1.12102594 |
| 88 | MP0001542_abnormal_bone_strength | 1.11543459 |
| 89 | MP0005408_hypopigmentation | 1.11324727 |
| 90 | MP0003718_maternal_effect | 1.10470296 |
| 91 | MP0004858_abnormal_nervous_system | 1.10011672 |
| 92 | MP0004084_abnormal_cardiac_muscle | 1.09171114 |
| 93 | MP0009643_abnormal_urine_homeostasis | 1.09116063 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 1.08582345 |
| 95 | MP0000490_abnormal_crypts_of | 1.06870610 |
| 96 | MP0008872_abnormal_physiological_respon | 1.06204825 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 1.04323343 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03101504 |
| 99 | MP0001348_abnormal_lacrimal_gland | 1.02295694 |
| 100 | MP0009764_decreased_sensitivity_to | 1.01497078 |
| 101 | MP0001919_abnormal_reproductive_system | 1.01435585 |
| 102 | MP0002019_abnormal_tumor_incidence | 1.01256659 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 1.01253139 |
| 104 | MP0000613_abnormal_salivary_gland | 1.00804546 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 1.00736670 |
| 106 | MP0001661_extended_life_span | 1.00485929 |
| 107 | MP0009697_abnormal_copulation | 0.99315262 |
| 108 | MP0003878_abnormal_ear_physiology | 0.99182221 |
| 109 | MP0005377_hearing/vestibular/ear_phenot | 0.99182221 |
| 110 | MP0002006_tumorigenesis | 0.98901109 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.98887624 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.97776580 |
| 113 | MP0001873_stomach_inflammation | 0.96743697 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.96732923 |
| 115 | MP0005266_abnormal_metabolism | 0.96620044 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.96038125 |
| 117 | MP0000749_muscle_degeneration | 0.94883847 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.94477100 |
| 119 | MP0003938_abnormal_ear_development | 0.94076035 |
| 120 | MP0004133_heterotaxia | 0.93418106 |
| 121 | MP0000609_abnormal_liver_physiology | 0.92836797 |
| 122 | MP0005330_cardiomyopathy | 0.91797826 |
| 123 | MP0002210_abnormal_sex_determination | 0.90492727 |
| 124 | MP0004381_abnormal_hair_follicle | 0.89977082 |
| 125 | MP0000372_irregular_coat_pigmentation | 0.88506564 |
| 126 | MP0004142_abnormal_muscle_tone | 0.88355987 |
| 127 | MP0003866_abnormal_defecation | 0.88051022 |
| 128 | MP0009763_increased_sensitivity_to | 0.87784435 |
| 129 | MP0002102_abnormal_ear_morphology | 0.87010688 |
| 130 | MP0000343_altered_response_to | 0.84817928 |
| 131 | MP0008995_early_reproductive_senescence | 0.84537590 |
| 132 | MP0005084_abnormal_gallbladder_morpholo | 0.83351738 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.82892802 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.82003407 |
| 135 | MP0009278_abnormal_bone_marrow | 0.81855502 |
| 136 | MP0003123_paternal_imprinting | 0.81828402 |
| 137 | MP0000358_abnormal_cell_content/ | 0.81777498 |
| 138 | MP0000313_abnormal_cell_death | 0.81728481 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.81660789 |
| 140 | MP0009250_abnormal_appendicular_skeleto | 0.81511874 |
| 141 | MP0001145_abnormal_male_reproductive | 0.81233571 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.80389338 |
| 143 | MP0001666_abnormal_nutrient_absorption | 0.80101852 |
| 144 | MP0003828_pulmonary_edema | 0.78921501 |
| 145 | MP0000703_abnormal_thymus_morphology | 0.78543306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatic necrosis (HP:0002605) | 4.31330166 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.15260560 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.11638562 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.05695586 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.03274537 |
| 6 | Increased CSF lactate (HP:0002490) | 3.84533118 |
| 7 | Acute encephalopathy (HP:0006846) | 3.80886818 |
| 8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.72123903 |
| 9 | Severe visual impairment (HP:0001141) | 3.70592930 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 3.69167271 |
| 11 | 3-Methylglutaconic aciduria (HP:0003535) | 3.51163580 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.47369254 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.47369254 |
| 14 | Reticulocytopenia (HP:0001896) | 3.36736514 |
| 15 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.24354540 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.19773978 |
| 17 | Lipid accumulation in hepatocytes (HP:0006561) | 3.19346444 |
| 18 | Increased serum lactate (HP:0002151) | 3.19312278 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.18489507 |
| 20 | Cerebral edema (HP:0002181) | 3.17672979 |
| 21 | Hyperthyroidism (HP:0000836) | 3.17346908 |
| 22 | Increased intramyocellular lipid droplets (HP:0012240) | 3.06402721 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.05833305 |
| 24 | Lactic acidosis (HP:0003128) | 3.04921764 |
| 25 | Increased muscle lipid content (HP:0009058) | 3.02326550 |
| 26 | Generalized aminoaciduria (HP:0002909) | 2.96288513 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 2.90177222 |
| 28 | Dicarboxylic aciduria (HP:0003215) | 2.87521462 |
| 29 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.87521462 |
| 30 | Exertional dyspnea (HP:0002875) | 2.86896194 |
| 31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.78132728 |
| 32 | Exercise intolerance (HP:0003546) | 2.76678760 |
| 33 | Renal Fanconi syndrome (HP:0001994) | 2.76587049 |
| 34 | Microretrognathia (HP:0000308) | 2.76050047 |
| 35 | Respiratory failure (HP:0002878) | 2.71607557 |
| 36 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.66695226 |
| 37 | Nausea (HP:0002018) | 2.65499788 |
| 38 | Porencephaly (HP:0002132) | 2.63365723 |
| 39 | Increased serum pyruvate (HP:0003542) | 2.61380803 |
| 40 | Abnormality of glycolysis (HP:0004366) | 2.61380803 |
| 41 | Aplastic anemia (HP:0001915) | 2.60303378 |
| 42 | Pendular nystagmus (HP:0012043) | 2.59659133 |
| 43 | Lethargy (HP:0001254) | 2.58043785 |
| 44 | Absent thumb (HP:0009777) | 2.56796603 |
| 45 | Reduced antithrombin III activity (HP:0001976) | 2.52401975 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.48814768 |
| 47 | Macrocytic anemia (HP:0001972) | 2.46803134 |
| 48 | Respiratory difficulties (HP:0002880) | 2.46504151 |
| 49 | Multiple enchondromatosis (HP:0005701) | 2.44873221 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43720897 |
| 51 | Glycosuria (HP:0003076) | 2.43311751 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 2.43311751 |
| 53 | Truncus arteriosus (HP:0001660) | 2.43214144 |
| 54 | Microvesicular hepatic steatosis (HP:0001414) | 2.42608118 |
| 55 | Cleft eyelid (HP:0000625) | 2.42263419 |
| 56 | Hypertensive crisis (HP:0100735) | 2.41708015 |
| 57 | Petechiae (HP:0000967) | 2.40990906 |
| 58 | CNS demyelination (HP:0007305) | 2.40394619 |
| 59 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.37653382 |
| 60 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.36949042 |
| 61 | Thrombocytosis (HP:0001894) | 2.36617057 |
| 62 | Rough bone trabeculation (HP:0100670) | 2.33878683 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33807575 |
| 64 | Sclerocornea (HP:0000647) | 2.31271947 |
| 65 | Prolonged neonatal jaundice (HP:0006579) | 2.30336763 |
| 66 | Cerebral hypomyelination (HP:0006808) | 2.30162323 |
| 67 | IgM deficiency (HP:0002850) | 2.29727978 |
| 68 | Rhabdomyolysis (HP:0003201) | 2.27179321 |
| 69 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.26053727 |
| 70 | Horseshoe kidney (HP:0000085) | 2.23032426 |
| 71 | Hyperglycinuria (HP:0003108) | 2.18757909 |
| 72 | Recurrent bacterial skin infections (HP:0005406) | 2.18333862 |
| 73 | Pallor (HP:0000980) | 2.17290726 |
| 74 | Asplenia (HP:0001746) | 2.17242127 |
| 75 | Hyperglycinemia (HP:0002154) | 2.16923379 |
| 76 | Short femoral neck (HP:0100864) | 2.15174555 |
| 77 | Opisthotonus (HP:0002179) | 2.12881046 |
| 78 | Pancreatic fibrosis (HP:0100732) | 2.11671665 |
| 79 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.11449849 |
| 80 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.10722857 |
| 81 | Hyperammonemia (HP:0001987) | 2.09235358 |
| 82 | Visual hallucinations (HP:0002367) | 2.05831290 |
| 83 | Pancytopenia (HP:0001876) | 2.05632802 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.05471566 |
| 85 | Abnormality of DNA repair (HP:0003254) | 2.03454188 |
| 86 | Hypoplasia of the uterus (HP:0000013) | 2.02797166 |
| 87 | Esophageal neoplasm (HP:0100751) | 2.02252580 |
| 88 | Neoplasm of head and neck (HP:0012288) | 2.02252580 |
| 89 | Palpitations (HP:0001962) | 2.00363710 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 1.99828030 |
| 91 | Methylmalonic acidemia (HP:0002912) | 1.98523008 |
| 92 | Pancreatic cysts (HP:0001737) | 1.98446101 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96127646 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96127646 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96127646 |
| 96 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.95749604 |
| 97 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94553655 |
| 98 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94553655 |
| 99 | Abnormal protein glycosylation (HP:0012346) | 1.94553655 |
| 100 | Abnormal glycosylation (HP:0012345) | 1.94553655 |
| 101 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.94122158 |
| 102 | Renal cortical cysts (HP:0000803) | 1.93737286 |
| 103 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92179855 |
| 104 | Abnormality of glycine metabolism (HP:0010895) | 1.92179855 |
| 105 | Concave nail (HP:0001598) | 1.91951717 |
| 106 | Oral leukoplakia (HP:0002745) | 1.91687215 |
| 107 | Obstructive lung disease (HP:0006536) | 1.91202677 |
| 108 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91202677 |
| 109 | Proximal tubulopathy (HP:0000114) | 1.90702752 |
| 110 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.89983716 |
| 111 | IgG deficiency (HP:0004315) | 1.89445104 |
| 112 | Neutropenia (HP:0001875) | 1.88843947 |
| 113 | Abnormality of reticulocytes (HP:0004312) | 1.88758967 |
| 114 | Abnormal number of incisors (HP:0011064) | 1.88216459 |
| 115 | Dysautonomia (HP:0002459) | 1.87614189 |
| 116 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.86065086 |
| 117 | Short 1st metacarpal (HP:0010034) | 1.86065086 |
| 118 | Tinnitus (HP:0000360) | 1.85247972 |
| 119 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.85196698 |
| 120 | Poor head control (HP:0002421) | 1.85147108 |
| 121 | Testicular atrophy (HP:0000029) | 1.84808793 |
| 122 | Cerebral palsy (HP:0100021) | 1.84634688 |
| 123 | Leukodystrophy (HP:0002415) | 1.84178585 |
| 124 | Metabolic acidosis (HP:0001942) | 1.83276282 |
| 125 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82099577 |
| 126 | Ragged-red muscle fibers (HP:0003200) | 1.80844892 |
| 127 | Squamous cell carcinoma (HP:0002860) | 1.80253882 |
| 128 | Abnormality of serum amino acid levels (HP:0003112) | 1.79986300 |
| 129 | Carpal bone hypoplasia (HP:0001498) | 1.79217452 |
| 130 | Vomiting (HP:0002013) | 1.78904449 |
| 131 | Autoimmune thrombocytopenia (HP:0001973) | 1.78348026 |
| 132 | Redundant skin (HP:0001582) | 1.78202787 |
| 133 | Severe muscular hypotonia (HP:0006829) | 1.76684460 |
| 134 | Hepatosplenomegaly (HP:0001433) | 1.76478172 |
| 135 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.75676285 |
| 136 | Gliosis (HP:0002171) | 1.74338013 |
| 137 | Increased IgM level (HP:0003496) | 1.73983721 |
| 138 | Methylmalonic aciduria (HP:0012120) | 1.73963492 |
| 139 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.72496761 |
| 140 | Emotional lability (HP:0000712) | 1.72272591 |
| 141 | Progressive muscle weakness (HP:0003323) | 1.72238537 |
| 142 | Hyperalaninemia (HP:0003348) | 1.71847666 |
| 143 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71847666 |
| 144 | Abnormality of macrophages (HP:0004311) | 1.70189650 |
| 145 | Birth length less than 3rd percentile (HP:0003561) | 1.68978265 |
| 146 | Optic disc pallor (HP:0000543) | 1.68168313 |
| 147 | Eczematoid dermatitis (HP:0000976) | 1.66952598 |
| 148 | Hypobetalipoproteinemia (HP:0003563) | 1.65285592 |
| 149 | Abnormality of renal resorption (HP:0011038) | 1.63341942 |
| 150 | Myoglobinuria (HP:0002913) | 1.63301195 |
| 151 | Increased serum ferritin (HP:0003281) | 1.62288430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.13047356 |
| 2 | NME2 | 3.47618348 |
| 3 | BUB1 | 3.42494725 |
| 4 | STK16 | 3.06022048 |
| 5 | WEE1 | 2.81348391 |
| 6 | BCKDK | 2.65808319 |
| 7 | EIF2AK1 | 2.58229459 |
| 8 | SMG1 | 2.48730117 |
| 9 | PIM2 | 2.47246380 |
| 10 | MAP4K1 | 2.18441760 |
| 11 | IRAK3 | 2.03787573 |
| 12 | TXK | 2.00957673 |
| 13 | TSSK6 | 1.98667282 |
| 14 | EIF2AK3 | 1.92264269 |
| 15 | BRSK2 | 1.90337207 |
| 16 | IRAK4 | 1.83477886 |
| 17 | TYK2 | 1.77219411 |
| 18 | MAP3K14 | 1.72616685 |
| 19 | TBK1 | 1.66352800 |
| 20 | MYLK | 1.65108688 |
| 21 | VRK1 | 1.61942925 |
| 22 | NEK1 | 1.53427465 |
| 23 | LIMK1 | 1.51488023 |
| 24 | OBSCN | 1.49504259 |
| 25 | ZAK | 1.49005652 |
| 26 | TEC | 1.48407699 |
| 27 | BLK | 1.47155535 |
| 28 | PRKD2 | 1.46880603 |
| 29 | MST4 | 1.43535159 |
| 30 | IKBKB | 1.43337889 |
| 31 | GRK1 | 1.41296446 |
| 32 | IKBKE | 1.36548332 |
| 33 | PDK3 | 1.32265331 |
| 34 | PDK4 | 1.32265331 |
| 35 | FLT3 | 1.30042978 |
| 36 | CDK19 | 1.29030293 |
| 37 | MAP3K12 | 1.28549387 |
| 38 | BTK | 1.28447687 |
| 39 | KIT | 1.26131399 |
| 40 | MAP4K2 | 1.25850132 |
| 41 | ZAP70 | 1.22762244 |
| 42 | TESK2 | 1.22371261 |
| 43 | ARAF | 1.15477164 |
| 44 | MAP2K3 | 1.14980084 |
| 45 | SRPK1 | 1.13427075 |
| 46 | ACVR1B | 1.12204304 |
| 47 | DAPK3 | 1.10795948 |
| 48 | NUAK1 | 1.09364137 |
| 49 | ADRBK2 | 1.09146768 |
| 50 | ILK | 1.08232520 |
| 51 | DAPK1 | 1.08053483 |
| 52 | CDK8 | 1.06567356 |
| 53 | PIM1 | 1.06503872 |
| 54 | PLK4 | 1.05243403 |
| 55 | KDR | 1.00919358 |
| 56 | STK4 | 0.97189688 |
| 57 | MAP3K3 | 0.94887172 |
| 58 | TLK1 | 0.93488499 |
| 59 | CCNB1 | 0.91990106 |
| 60 | CDC7 | 0.90937972 |
| 61 | NEK9 | 0.90934905 |
| 62 | NLK | 0.90854965 |
| 63 | ERN1 | 0.89603141 |
| 64 | MAPKAPK3 | 0.88818751 |
| 65 | JAK3 | 0.88061529 |
| 66 | RPS6KA4 | 0.88059324 |
| 67 | SYK | 0.87865953 |
| 68 | TRIB3 | 0.86234073 |
| 69 | CLK1 | 0.85939284 |
| 70 | PAK1 | 0.85761642 |
| 71 | PDK2 | 0.85221224 |
| 72 | MAP3K11 | 0.84822995 |
| 73 | MAP3K8 | 0.84531009 |
| 74 | TAF1 | 0.83104536 |
| 75 | CSNK1G3 | 0.81863515 |
| 76 | CDK7 | 0.81124479 |
| 77 | CHEK2 | 0.80966862 |
| 78 | PRKCI | 0.80864474 |
| 79 | DYRK2 | 0.80831810 |
| 80 | RPS6KB2 | 0.79642362 |
| 81 | EIF2AK2 | 0.75703078 |
| 82 | NME1 | 0.75322784 |
| 83 | AURKB | 0.75260837 |
| 84 | PLK1 | 0.74785612 |
| 85 | NEK2 | 0.74251919 |
| 86 | BRSK1 | 0.74250344 |
| 87 | EPHA2 | 0.73992186 |
| 88 | PBK | 0.73493292 |
| 89 | BRAF | 0.73141403 |
| 90 | ATR | 0.72149125 |
| 91 | GRK6 | 0.72128233 |
| 92 | MUSK | 0.72017515 |
| 93 | CSF1R | 0.71261029 |
| 94 | RPS6KA6 | 0.69036124 |
| 95 | PASK | 0.66827340 |
| 96 | TGFBR1 | 0.64830329 |
| 97 | GRK7 | 0.63039286 |
| 98 | ABL2 | 0.62962043 |
| 99 | PIK3CG | 0.62861069 |
| 100 | TTK | 0.62017557 |
| 101 | TAOK2 | 0.61843869 |
| 102 | PINK1 | 0.61648264 |
| 103 | INSRR | 0.60665441 |
| 104 | WNK4 | 0.60257569 |
| 105 | STK24 | 0.60189210 |
| 106 | BMX | 0.59940686 |
| 107 | DYRK3 | 0.59915572 |
| 108 | TIE1 | 0.59709574 |
| 109 | CSNK2A1 | 0.59303629 |
| 110 | IRAK1 | 0.58718156 |
| 111 | RPS6KA5 | 0.57701901 |
| 112 | CDK4 | 0.57325239 |
| 113 | LRRK2 | 0.56310459 |
| 114 | MAP2K6 | 0.56128548 |
| 115 | AURKA | 0.55773363 |
| 116 | ITK | 0.55298777 |
| 117 | FES | 0.54921737 |
| 118 | HIPK2 | 0.54605661 |
| 119 | LYN | 0.54509805 |
| 120 | MAPK11 | 0.54266704 |
| 121 | FGFR4 | 0.52779326 |
| 122 | MAPKAPK5 | 0.52341389 |
| 123 | RPS6KC1 | 0.51764362 |
| 124 | RPS6KL1 | 0.51764362 |
| 125 | STK10 | 0.48942583 |
| 126 | CSNK2A2 | 0.48875488 |
| 127 | CHUK | 0.48387000 |
| 128 | BMPR1B | 0.47826704 |
| 129 | TNK2 | 0.45395794 |
| 130 | TESK1 | 0.45360910 |
| 131 | JAK1 | 0.44330435 |
| 132 | MAP2K2 | 0.42358554 |
| 133 | GRK5 | 0.40202490 |
| 134 | EPHB1 | 0.39206008 |
| 135 | CHEK1 | 0.36754987 |
| 136 | CSNK1A1L | 0.36680515 |
| 137 | CDK9 | 0.35710664 |
| 138 | PRKD3 | 0.33060065 |
| 139 | MAPKAPK2 | 0.32936571 |
| 140 | LMTK2 | 0.30752014 |
| 141 | PAK4 | 0.30504983 |
| 142 | CSNK1G1 | 0.29544863 |
| 143 | AKT2 | 0.28988819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.65659030 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.59962300 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.95842680 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.73626756 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.43512819 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.30444460 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.29034295 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.21727427 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17152910 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.17019175 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.07497483 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.05317720 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 1.88988050 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.77469974 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71945139 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.68688858 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.64946951 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.64037283 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.54005224 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.52699247 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.50613061 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.47689639 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44883734 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44784067 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34389328 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32669232 |
| 27 | Spliceosome_Homo sapiens_hsa03040 | 1.32454893 |
| 28 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32091794 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29534249 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26364451 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.24472393 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23613297 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.23521850 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.23058586 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22415415 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19665569 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.15121201 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14992010 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.13500701 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11895346 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.11003342 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07755601 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06092098 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05034157 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04144035 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01588388 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00899035 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00597810 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98399770 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95408504 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 0.94569559 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94397835 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.93310645 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92639666 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92256259 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91686573 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 0.91404942 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90443289 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90437600 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.90176035 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89780326 |
| 62 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89499398 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88923259 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88057653 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85203629 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85144053 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84972616 |
| 68 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84962807 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82431164 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82421272 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82395913 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81642338 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78900762 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76382751 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75625200 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75540161 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74034569 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73806759 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73669623 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.72364256 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70062754 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.69221113 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69137253 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68089060 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66471004 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66014181 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65707204 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63392606 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63364374 |
| 90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62583345 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62519775 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61726860 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61683280 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60468952 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57536568 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56326124 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56326063 |
| 98 | Phototransduction_Homo sapiens_hsa04744 | 0.55395084 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55275269 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54882516 |
| 101 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53954294 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53612954 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53417595 |
| 104 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52868781 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52565016 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51104418 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50204426 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47491116 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47163956 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42253905 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.41612330 |
| 112 | Asthma_Homo sapiens_hsa05310 | 0.41268302 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40831583 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40667350 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.39034373 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37472207 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36087670 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.33824230 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33509723 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32370541 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29562549 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26727107 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26351980 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.22295101 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.19044407 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.18827737 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18361061 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.17054866 |

